Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Drug development and how best to work with specialised Rare Disease networks Dr Jean-Meidi Alili, senior pharmacist at G2M; Dr Jeff Keefer, IQVIA; Dr Joanne Hackett, IQVIA; Dominic Tyer, pharmaphorum This webinar will take place on Tuesday 9th November at 12:00 pm GMT / 1:00 pm CET. Far more common than initially thought, rare disease treatments r... 4 weeks ago | 61 mins Ask The Experts Roundtable MPC Alliance 10:45AM PT | Ask the Experts Roundtable Pull up a seat at this virtual roundtable and ask your questions with a live dial-in bridge for a fully intera... 1 month ago | 63 mins Quantifying the Impacts of Strategic and Extreme/Rare Event Risks Rafael Hartke, CEO of Imagine Risks and Analytics Risk matrices are widely used in risk analysis to account for the effects of external factors or rare/extreme events that may occur within a project. ... 5 months ago | 68 mins The Magic of AI | Addressing the Puzzle of Rare Diseases with A.I. Pfizer and Dell Technologies Dell Technologies, Thomas Henson, Global Business Development Manager AI/analytics two special guests from Pfizer, Mark Soued, VP, Rare Cardiology Fra... 7 months ago | 24 mins Operational & Regulatory Factors in Cross-Border Enrollment in Rare Disorders Hanna Wide Director, Program Delivery Rare Diseases & Pediatrics at Premier Research Researchers are more focused than ever on finding treatments and cures for rare diseases, encouraged by a regulatory environment that is increasingly ... 1 year ago | 19 mins Wind and Solar Energy Expansion Growth: Implications for Commodity Demand? Feng Zhao, Matthew Watkins, Jorn de Linde, Chenfei Wang and Daan de Jonge As renewable energy technologies mature, there has been a continuous drop in their costs, which has made them a competitive alternative to fossil fuel... 3 months ago | 69 mins Novel Trial Approaches for Rare Cancer Patients Rupa Doshi, PhD, Executive Director – Program Strategy, Oncology and Sameena Sharif, PhD, Senior Vice President, Product Stra Best practices for managing ongoing cell and gene therapy trials Rare cancers account for 22 percent of cancer diagnoses worldwide, yet there is no un... 1 year ago | 58 mins Rare Oncology Research in the 21st Century Sachin Kulkarni and Juliet M. Moritz Study of rare cancers tends to look more like rare disease research than standard oncology research. This webinar will highlight some of the challenge... 2 years ago | 61 mins Natural History or Registry Study? Conducting Rare Disease Research Angi Robinson and Juliet Moritz Sound drug development requires a comprehensive understanding of the disease being treated. To design reliable clinical studies and achieve meaningful... 2 years ago | 61 mins River and Mercantile update - R&M UK Micro Cap Investment Company George Ensor George Ensor will provide an update on the R&M UK Micro Cap Investment Company, and will explain how the company offers investors a rare opportunity t... 4 months ago | 28 mins The Black Swan Is Dead—What’s Next for Supply Chain Resilience? Interos founder and CEO Jennifer Bisceglie and Johnathan Eaton, Principal, Supply Chain Practice Leader at Grant Thornton Supply chain disruptions are no longer rare or unpredictable. Which means not knowing isn’t an option anymore. This change has created a new business... 5 months ago | 24 mins Anatomy of real-time at Paddypower Betfair Alexandru Objelean & Rares Rusu from Paddypower Betfair & Andy Steed, Big Data LDN Couchbase NoSQL has started small at Paddypower Betfair. From its early beginnings, as an alternative to our classic relational databases, it has grow... 10 months ago | 44 mins Legg Mason IF RARE Global Infrastructure Income Fund Update Shane Hurst, Portfolio Manager, RARE Fund Update with Portfolio Manager Shane Hurst 2 years ago | 40 mins Rare Disease Research: Conducting Clinical Trials Where the Patients Are Alison Sampson, Hanna Wide, MSc Clinical Trials in Rare Diseases: Where to find Rare Disease Patients Working with sites where the Patients are Supporting the Site Recruitmen... 2 years ago | 47 mins Drug repurposing for rare diseases: an integrated data driven approach Jabe Wilson; Megan Golden Pharma R&D for rare diseases is, itself, rare, because patient populations are perceived as insufficient to deliver ROI. Drug repurposing eliminates t... 2 years ago | 53 mins The Implications of a World Without China Tim Harvey, CEO, NTree Home to 25% of Fortune 500 companies, manufacturing 90% of our laptops, and refining 80% of our rare earth metals – the world would be a different pla... 1 year ago | 33 mins Hunting for Advanced Threats - Tips and Tricks Ken Donze, Security Engineer The COVID-19 pandemic has presented a once-in-a-lifetime opportunity for attackers. In a rare occurrence, security professionals know cyber attacks ar... 1 year ago | 31 mins Paddy Power - Real-time Personalised customer interaction at scale Perry Krug, Chris Bridgland, Couchbase | Alexandru Objelean, Rares Rusu, Paddy Power BetFair How do you build a customer interaction platform that is agile enough to respond to constantly changing requirements and still able to perform at scal... 2 years ago | 40 mins Improving Regulatory and Operational Performance in Orphan Drug Development Nach Davé and Kimberly Glen Today more than ever, regulatory bodies are providing a progressive platform for rare disease drug development. Extensions to existing regulations and... 2 years ago | 57 mins No Opportunity Unturned: Optimizing Orphan Drug Development Angi Robinson, Lisa Pitt, and Juliet Moritz Regulations supporting orphan drug research have been evolving for more than 20 years, providing incentives and guidance for development of potentiall... 2 years ago | 59 mins Coffee Break with Helen Beal: Intelligent Observability for ITOps Helen Beal, Chief Ambassador, DevOps Institute and Dave Casper, CTO, Moogsoft These days, an ITOps team with time on their hands is a rare sight. Monolithic, legacy infrastructure that is inherently fragile fuels a fraught worki... 9 months ago | 60 mins Cook Your Dinner, Don’t Cook Your Devices Scott Scheferman, Principal Cyber Strategist at Eclypsium In this rare EC-Council event, you’ll learn how to properly select, prepare & plate an amazing rack of lamb and sides, while engaging your intellectua... 7 months ago | 91 mins How DocuSign Scales Content Operations to Pave the Way for Customer Self-Service Dusty Clark and Deana Falk of DocuSign Thanks to an extended period of hypergrowth – further accelerated by the great digital transformation of 2020 – DocuSign has evolved from a single-pro... 6 months ago | 58 mins Real-time Personalised customer interaction at scale Perry Krug, Chris Bridgland, Couchbase | Alexandru Objelean, Rares Rusu, Paddy Power BetFair How do you build a customer interaction platform that is agile enough to respond to constantly changing requirements and still able to perform at scal... 2 years ago | 41 mins 3 Things to Look for In an IoT Connectivity Provider Jason Chien, Principal Product Marketing Manager, Aeris Cellular connectivity is everywhere, leaving many with the impression that providers are more or less the same. When it comes to IoT, the reality is f... 1 year ago | 60 mins Load more
